| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05201781 | A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel | Multiple Myeloma | Recruiting |
| Phase 3 | |||
| NCT05257083 | A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by… | Multiple Myeloma | Active, Not Recruiting |
| NCT04181827 | A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation… | Multiple Myeloma | Active, Not Recruiting |
| NCT04923893 | A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a… | Multiple Myeloma | Active, Not Recruiting |
| Phase 2 | |||
| NCT06940297 | Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or… | Recurrent Multiple Myeloma | Recruiting |
| NCT07149857 | A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel | Multiple Myeloma | Recruiting |
| NCT05767359 | CAR- PRISM (PRecision Intervention Smoldering Myeloma) | Multiple Myeloma | Active, Not Recruiting |
| NCT06550895 | A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants… | Multiple Myeloma | Active, Not Recruiting |
| NCT06577025 | A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab… | Multiple Myeloma | Active, Not Recruiting |
| Phase 1 | |||
| NCT07093554 | Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by… | Relapse Multiple Myeloma | Recruiting |
| NCT06623630 | Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to… | Multiple Myeloma | Recruiting |